the support you need hemostatic control you want - stryker · hemostatic products and nasopore...

4
Neuro Spine ENT The support you need hemostatic control you want HemoPore ® Hemostatic Bioresorbable Nasal Dressing Chitosan lactate Firm compression strength/stenting

Upload: nguyenanh

Post on 04-Apr-2019

228 views

Category:

Documents


1 download

TRANSCRIPT

Neuro Spine ENT

The support you needhemostatic control you want

HemoPore®

Hemostatic Bioresorbable Nasal Dressing

Chitosan lactate

Firm compression strength/stenting

All the qualities you like, now with hemostatic action

You asked, and we responded. Our new HemoPore bioresorbable nasal dressing delivers all the qualities you like in NasoPore® dressings, plus the added clinical benefits of a hemostatic agent. With chitosan lactate blended directly into our proprietary synthetic polymer dressing, testing showed they worked together without sacrificing any existing performance characteristics.1 The dressing’s firm compression strength further aids hemostasis, helps prevent adhesions and minimizes edema while maintaining structure separation and stabilization. The result is reliable tissue support and hemostatic control that avoids the need for separate topical hemostats.

Unique two-way action Tissue support plus platelet activation and aggregation

�5�In vitro findings showed HemoPore dressings prompted higher platelet activation and aggregation than similar hemostatic products and NasoPore Firm, thus accelerating blood coagulation and healing.2 Combined with 36-48 hours of tissue support and stenting, HemoPore dressings are designed to fulfill your clinical needs on many levels.

6000

5000

4000

3000

2000

1000

TxB

2 [p

g/m

L]

HemoP

ore

XeroGel

®

PosiSep

TM

NasoPore

® Firm

Platelet Activation

Error bars are representative of standard error of the mean.

5

4

3

2

1

0

Ohm

/min

PosiSep

TM

XeroGel

®

NasoPore

® Firm

HemoP

ore

Platelet Aggregation

The stabilization and hemostatic control you want

– Inherent chitosan lactate hemostat helps avoid need for topical hemostats

– Supports vital tissue structures for 36-48 hours1

– Fragments in 10-14 days1

– Helps prevent adhesions

– Clears through natural mucosal flow, eliminating manual or painful removal

– No mixing, moistening, injection syringes or other prep needed

A nasal dressing to suit every need

The chart below may be used as a guide to help select the nasal dressing best suited to your needs. All nasal dressings may be ordered through a single point of purchase.

HemoPoreWith Hemostatic Agent

NasoPore®FDFast Degrading

NasoPore®

StandardNasoPore®

FirmNasoPore®

Extra Firm

Fragmentation Time 10-14 days 5-7 days 7-10 days 10-12 days 12-14 days

Tissue Support/Shape Integrity

36-48 hours 36-48 hours 36-48 hours 36-48 hours 36-48 hours

Compression Strength/Stenting

Firm Firm Gentle Firm Extra firm

Absorption Capacity Average 20x* its weight

Average 20x* its weight

Average 20x* its weight

Average 20x* its weight

Average 20x* its weight

Hydrophilic (does not swell) P P P P P

Material 100% synthetic proprietary polymer with a chitosan lactate hemostatic agent

100% synthetic proprietary polymer

100% synthetic proprietary polymer

100% synthetic proprietary polymer

100% synthetic proprietary polymer

Chitosan

Proven to drive the wound healing process3

Several ground-breaking medical advancements have emerged from military science, and chitosan as a hemostatic agent is no exception3. There are several publications on the use of this polysaccharide in medical products to drive the wound healing process:

– Spurs resting platelets into activation; helping them adhere to collagen4-6

– Fosters platelet aggregation; forming platelet plugs that accelerate blood coagulation4, 6-8

– Has inherent anti-microbial properties9

– Helps avoid the need for direct acting topical hemostats

– Complies with safety and biocompatibility standards for use in humans

*+/- 8

The information presented in this brochure is intended to demonstrate the breadth of Stryker product offerings. Always refer to the package insert, product label and/or user instructions before using any Stryker product. Products may not be available in all markets. Product availability is subject to the regulatory or medical practices that govern individual markets. Please contact your Stryker representative if you have questions about the availability of Stryker products in your area.

Products referenced with TM designation are trademarks of Stryker. Products referenced with ® designation are registered trademarks of Stryker.

Literature Number: 9100-003-261 Rev NoneG55/PS

See HemoPore Instructions for Use (IFU) for complete details.

HemoPore should not be used in patients who have known allergies to shellfish.

Copyright © 2015 StrykerPrinted in USA

Stryker Neuro Spine ENT4100 East Milham AvenueKalamazoo, MI 49001 USAt: 269 323 7700 f: 800 999 3811toll free: 800 253 3210

www.stryker.com/NSE

Ordering is easy

All variations of our bioresorbable solutions are conveniently available through a single source. To order, call Customer Service at 800-253-3210 or contact your Stryker NSE sales representative. For more details visit www.stryker.com/bioresorbables

References

1. Stryker internal performance data on file.2. "Thrombogenic Performance of Stryker® HemoPore® Hemostatic Bioresorbable Nasal Dressing and

Other Marketed Nasal Dressings." Stryker internal white paper, 9100-003-317 Rev None.3. Waibel KH, Haney B, Moore M, Whisman B, Gomez R. "Safety of chitosan bandages in shellfish allergic

patients." Mil Med. 2011; 176(10):1153-6.4. Bhaskara Rao S, Sharma CP. "Use of chitosan as a biomaterial: Studies on its safety and hemostatic

potential." J Biomedical Materials Res. 1997; 34:21-28.5. He Q, Gong K, Ao Q, Ma T, Yan Y, Gong Y, Zhang X. "Positive charge of chitosan retards blood

coagulation on chitosan films." J Biomaterials Applications 2011; 27(8):1032-45.6. Chou T, Fu E, Wu C, Yeh J. "Chitosan enhances platelet adhesion and aggregation." Biochem. Biophys.

Res. Commun. 2003; 302:480-83.7. Wu C, Ko F, Huang T, Teng C. "Mechanisms-regulated platelet spreading after initial platelet contact with

collagen." Biochem. Biophys. Res. Commun. 1996; 220:388-93.8. Jobling J, Eyre L. "Haemostasis, blood platelets and coagulation." Anaesthesia Intensive Care Med.

2013; 14 (2):51-53.9. Dai, T., Huang, Y., Tanaka, M. “Chitosan preparations for wounds and burns: antimicrobial and wound-

healing effects.” National Institute of Health. 2011; 9(7):857-879.

We’re laser focused on Neuro, Spine and ENT. Our instruments, technology, education and support are all tailored to your specialties to help fulfill your unique needs and potentially make a positive difference in your day and outcomes.

• High Speed Drills (electric and pneumatic)

• Attachments and cutting accessories

• Sonopet® Ultrasonic Aspirator

• Bone Mill

• SilverGlide® Bipolar Forceps

• Microdebrider

• NasoPore® Bioresorbable Nasal Dressings

• HemoPore® Hemostatic Bioresorbable Nasal Dressing

• OtoPore® Bioresorbable Ear Dressings

• Surgeon headlights and other accessories in support of NSE specialties

Neuro Spine ENT

Part Number Description Quantity/Pack

HemoPore (with Hemostatic Agent)

5400-020-208 8 cm (3.15 inch) 8

NasoPore FD (Fast Degrading)

5400-020-108 8 cm (3.15 inch) 8

NasoPore Standard

5400-010-004 4 cm (1.57 inch) 8

5400-010-008 8 cm (3.15 inch) 8

NasoPore Firm

5400-020-004 4 cm (1.57 inch) 8

5400-020-008 8 cm (3.15 inch) 8

NasoPore Extra Firm

5400-030-004 4 cm (1.57 inch) 8

5400-030-008 8 cm (3.15 inch) 8